Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 117
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial...
Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications...
Psychedelic Research Bulletin: January 2023
PT389 – The Art of Ecstasy: The 90’s British Club Scene...
Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team...
Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit...
Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023...
FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR...
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT
Load more
